Immune monitoring of phase II trial of hu14.18-IL2 for patients with metastatic melanoma.
Mark R. Albertini
Research Funding - Merck Serono
Jacquelyn A Hank
No relevant relationships to disclose
Brian Christopher Gadbaw
No relevant relationships to disclose
Jordan Kostlevy
No relevant relationships to disclose
Jennifer Haldeman
No relevant relationships to disclose
Jacek Gan
No relevant relationships to disclose
KyungMann Kim
No relevant relationships to disclose
Jens C. Eickhoff
No relevant relationships to disclose
Stephen Gillies
Employment or Leadership Position - Merck Serono (U)
Consultant or Advisory Role - Merck Serono (U)
Paul M. Sondel
Research Funding - Merck Serono